HuagongsheHuagongshe Chemistry Print Report · For research reference only
1-(Bromomethyl)-3-(trifluoromethoxy)benzene → 4-{5-[4-Methoxymethyl-4-(3-trifluoromethoxybenzyl)piperidine-1-ylmethyl]-2-methylimidazol-1-ylmethyl}benzonitrile hydrochloride salt
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 1-(Bromomethyl)-3-(trifluoromethoxy)benzene | HCID 737176 | — |
| Reactant | 1-(4-Cyanobenzyl)-5-chloromethyl-2-methylimidazole hydrochloride salt | HCID 21193348 | — |
| Reactant | N-tert-butoxy-carbonyl-4-(3-trifluoromethoxybenzyl)-4-hydroxymethylpiperidine | HCID 86754053 | — |
| Product | 4-{5-[4-Methoxymethyl-4-(3-trifluoromethoxybenzyl)piperidine-1-ylmethyl]-2-methylimidazol-1-ylmethyl}benzonitrile hydrochloride salt | HCID 21193264 | — |
Reaction Steps
The title compound was prepared using the protocol described in Example 30, Step A-C using 3-(trifluoromethoxy)benzyl bromide in Step B, and in Example 52, Step B-E substituting N-tert-butoxycarbonyl-4-(3-methylbenzyl)-4-hydroxymethylpiperidine with N-tert-butoxy-carbonyl-4-(3-trifluoromethoxybenzyl)-4-hydroxymethylpiperidine in Step B, and substituting 1-(4-cyanobenzyl)-5-chloromethyl-imidazole hydro-chloride salt with 1-(4-cyanobenzyl)-5-chloromethyl-2-methylimidazole hydrochloride salt in Step E.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06248756B1 |
| Source dataset | uspto-grants-2001_06 |
| ORD ID | ord-0f448fe121794d109f6caa8f39919b6b |
| Source note | uspto-grants-2001_06 |